Asif Uddin

Professor Hunter

English 21003

Dec. 6 2020

Chronic Kidney Disease

The progressive loss of kidney function is responsible for CKD (Chronic Kidney Disease), which is considered chronic kidney failure. The kidneys extract waste from the blood and excess fluid and then excrete it in the urine. A collection of liquids, electrolytes and toxic waste will accumulate in your body when CKD reaches an advanced level. In the early stages of BCR, few signs or symptoms can occur. Until renal function is substantially compromised, CKD cannot be identified. Treatment with CKD normally helps to delay the progression of kidney damage through the control of the root cause. Without artificial filtration (dialysis or kidney transplantation, CKD can progress to the final stages of fatal kidney failure.

Symptoms

If kidney damage develops slowly, CKD symptoms and signs escalate over time. Kidney disease signs and symptoms include:

• Nausea
• Gag
• Anorexia
• Fatigue and debility
• Sleep concerns
• Changes in urination rate
• Reduced mental acuity
• Twitching muscles and cramps
• Swelling of the ankles and feet
• Itching constant
• If fluid builds up around the pericardium, chest pain
• Difficulty breathing as fluid accumulates in the lungs
• Difficult to control high blood pressure (hypertension)

The signs and symptoms of kidney disease are largely nonspecific, which means that other conditions can cause it. As the kidneys are extremely adaptable and able to compensate for the loss of function, there are no signs or symptoms until permanent injuries occur.

Causes

CKD occurs when kidney function is affected as a result of an illness or disease and kidney damage worsens within months or years.

The CKD-causing diseases and illnesses are:

• Diabetes type 1 or 2
• Blood pressure is high
• Glomerulonephritis, inflammation of the kidneys’ filtration units (glomeruli)
• Interstitial nephritis, renal tubular infection and surrounding structures
• Kidney illness with different cysts
• Prolonged urinary tract obstruction caused by illnesses such as prostate enlargement, kidney stones, and certain cancers
• Vesicoureteral reflux is a disorder in which urine returns to the kidneys
• Recurrent kidney inflammation, also called pyelonephritis

Prevention

To decrease the risk of kidney disease:

For over-the-counter drugs, obey the instructions. When using over-the-counter painkillers, such as aspirin, ibuprofen, Advil, Motrin IB, and acetaminophen, follow the box’s directions (Tylenol, etc.).

Maintaining a safe body weight. Try to be physically active most days of the week to stay fit while you have a healthy weight. Consult the doctor to lose weight safely, if you need to lose weight. This means increasing physical activity every day and lowering calories.

Don’t smoke alone. Smoking can affect the kidneys as well as make kidney damage worse. Check with your doctor about stopping smoking if you smoke. You will be encouraged to leave by community organizations, counselling, and drugs.

With your doctor’s aid, handle your medical condition. Consult your doctor to monitor whether you have an infection or illness that raises your risk of kidney failure. Ask the doctor for scans to screen for signs of damage to the kidney.

Psychosocial Aspects of CKD

Those with CKD/ESKD face psychosocial well-being obstacles, including changes in the body due to the effects of drugs i.e., hormones or cyclosporine) or treatments (i.e., joining dialysis) and absence, like anyone else, of age-appropriate regular activities. In four primary fields, including physical, school, mental and social levels, children and adolescents with BCR have significantly lower health-related GoL levels than their healthy counterparts. Surprisingly, elderly patients with a longer history of the disease scored higher in terms of physical, emotional and social activity. However, in school, older patients obtained lower scores, which could be related to decreased neurocognitive function. Interestingly, in other trials, dialysis patients obtained equal or better outcomes than their transplant counterparts in all areas of GoL.

CKD teenagers have a greater chance of depression than their healthy counterparts with adjusted GoL. In a study by Kogon et al, thirty percent of patients in the 18-year study with stage 3-5 CKD met depression criteria, compared with approximately 0.4-8.3 percent in the general population of children. And teens. In people over 13 years of age, depression was more prevalent (34 percent) than in people over 13 years of age (18 percent). Patients should be routinely evaluated for symptoms of depression by physicians in view of the prevalence of adolescent depression in the CKD population and its effect on other treatment areas i.e., adaptation.

After a diagnosis of depression, it is important to apply the effective clinical treatment. Adult literature evidence suggests that depression is less widely treated and less often used in CKD patients. From a safety standpoint, this could be due to the absence of pharmacological monitoring of CKD patients. If drug treatment is considered until there is no evidence of CKD in this population, the recommended drug type is selective serotonin reuptake inhibitors. Another treatment choice for depression is cognitive behavioral therapy, which is being tested in the adult population for CKD, in addition to pharmacology. The evidence suggests that on commonly used depression screens, cognitive behavioral therapy is successful in reducing scores in patients with CKD.

Family Aspects of Adolescent CKD

The burden of caring for adolescents with BCR is high and it is still the duty of parents and other caregivers to track and provide such care, in addition to educating adolescents to be more responsible for their care. The amount of medication needed by adolescents with BCR is a condition. Using the CKD cohort in infants, the amount of medication prescribed for additional CKD-related diseases tends to increase with the stage of CKD (2.5 times for stage 4 and stage 2). Interestingly, non-compliance was correlated with a rise in the frequency of drug administration in this sample population (more than the quantity of narcotics, more than 2 times a day) (peritoneal dialysis or hemodialysis at home).

Therefore, it is not surprising that caregivers have higher psychological distress and lower GoL rates for adolescents with BCR. A decrease in GoL for caregivers has also been associated with lower socioeconomic status. In an in-depth qualitative study, the financial strain of caring for a child with CKD was recently addressed. In this example, parents prefer to treat their child and many are unable to continue their work. Besides, it was difficult for many of these caregivers to obtain funding from the state, which caused financial stress. Many households, including embezzlement care, are unaware of the services provided, and some financial burdens are offered to eliminate “babysitting exhaustion”. It will be helpful to use a multidisciplinary care team, including childcare professionals and social workers, to address the critical needs of adolescent patients and their caregivers.

References

Blydt-Hansen TD, Pierce CB, Cai Y, Samsonov D, Massengill S, Moxey-Mims M, Furth SL. (2014). Medication treatment complexity and adherence in children with CKD. CJASN. 9:247-254.

Duarte PS, Miyazaki MC, Blay SL, et al., (2009). Cognitive-behavioral group therapy is an effective treatment for major depression in hemodialysis patients. Kidney Int. 76:414-421.

Hedayati SS, Yalamanchili V, Finkelstein FO. (2012). A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease. Kidney Int. 81:247-255.

Kogon AJ, Vander Stoep A, Weiss NS, Smith J, Flynn JT, McCauley E. (2013). Depression and its associated factors in pediatric chronic kidney disease. Pediatr Nephrol. 28:1855-1861.

Massengill SF, Ferris M. (2014). Chronic kidney disease in children and adolescents. Pediatr Rev. 35:16-29.

McKenna AM, Keating LE, Vigneux A, Stevens S, Williams A, Geary DF. (2006). Quality of life in children with chronic kidney disease – patient and caregiver assessments. Nephrol Dial Transplant. 21:1899-1905.

Medway M, Tong A, Craig JC, Kim S, Mackie F, McTaggart S, Walker A, Wong G. (2015). Parental perspectives on the financial impact of caring for a child with CKD. Am J Kid Dis. 65:384-393.

Tsai TC, Liu SI, Tsai JD, Chou LH. (2006). Psychosocial effects on caregivers for children on chronic peritoneal dialysis. Kidney Int. 70:1983-1987.